Summary. Antisera against chromogranin A and B and secretogranin II were used for analysing the bovine pancreas by immunoblotting and irnmunohistochemistry. All three antigens were found in extracts of fetal pancreas by one dimensional immunoblotting. A comparison with the soluble proteins of chromaffin granules revealed that in adrenal medulla and in pancreas antigens which migrated identically in electrophoresis were present. In immunohistochemistry, chromogranin A was found in all pancreatic endocrine cell types with the exception of most pancreatic polypeptide-(PP-) producing cells. For chromogranin B, only a faint immunostaining was obtained. For secretorgranin II, Aand B-cells were faintly positive, whereas the majority of PP-cells exhibited a strong immunostaining for this antigen. These results establish that chromogranins A and B and secretogranin II are present in the endocrine pancreas, but that they exhibit a distinct cellular localization.
Introduction
The acidic soluble proteins of bovine ehromaffin granules have been collectively named ehromogranins (Blaschko et al. 1967) . Their main component, chromogranin A, has been isolated and characterized (Helle 1966; Smith and Winkler 1967; Smith and Kirschner 1967) and finally the primary amino acid sequence has been established (Benedum et al. 1986; Iancangelo et al. 1986 ). Chromogranin A is synthesized as a proprotein which within chromaffin granules is processed by endogenous proteases (Kilpatrick et al. 1983; Falkensammer et al. 1985 a) . Thus, mature chromaffin granules contain a family of immunologically related chromogranin A proteins (see Winkler et al. 1986 ). In addition to these chromogranins A, chromaffin granules contain at least two other groups of acidic proteins (see Winkler et al. 1986 ). According to a recent nomenclature proposal , we are using the terms chormogranins B and secretorgranins II for these two protein families (proproteins plus endogenous breakdown products).
Chromogranin A and B and secretogranin II are widely distributed in endocrine tissues (Cohn et al. 1982; O'Connor 1983; Wilson and Lloyd 1984; Rindi et al. 1986; Lassmann et al. 1986; Rosa et al. 1985) and all three antigens have been demonstrated immunohistochemically in the endocrine pancreas of several species Lloyd et al. 1984 ; Fischer-* To whom offprint requests should be sent Lassmann et al. 1986; Hagn et al. 1986; Rindi et al. 1986) .
Recently, the cellular distribution of chromogranin A has been studied in detail for the bovine endocrine pancreas (Ehrhart et al. 1986 ) and for the endocrine pancreas of nine other mammalian species ). In bovine pancreatic islets insulin-, glucagon-, and somatostatin-producing cells exhibited chromogranin A-like immunoreactivities. They were exclusively confined to the secretory vesicles. Most of the pancreatic polypeptide-(PP-) producing cells, however, were unreactive towards chromogranin A antiserum.
As yet it is unclear, whether the pancreatic chromogranin A has the same molecular form as chromogranin A isolated from the adrenal medulla. Proteins with a molecular size of about 20 kD reacting with chromogranin A antibodies have been observed in secretory vesicles isolated from rat insulinomas and in extracts of whole bovine pancreas (Nolan et al. 1985; Hutton et al. 1985) . On the other hand, immunoblot studies with extracts of human endocrine pancreas indicated that the molecular size (75000). of the pancreatic chromogranin A was identical to that of the adrenal antigen .
In the present paper we analyze the molecular properties of chormogranin A, ehormogranin B and secretogranin II of the bovine pancreatic islet by immunochemical techniques and determine their cellular distribution by immunohistochemistry.
Materials and methods

Immunoblotting procedures
Fresh pancreatic tissue from fetal calves (body weight about 6 kg) was obtained at the local slaughterhouse in Ulm. It was kept in an icecold medium (20 mM Mops, 0.5 mM EGTA, 340 mM sucrose, 1 mM PMSF, pH 7.3) and transported to the laboratory. The tissue was chopped into small pieces using sissors. Homogenization of the fetal tissue (10 g tissue/30 ml medium) was performed in a loose-fitting Teflon-to-glass homogenizer by 5 downward strokes. The homogenate was centrifuged at 2500 • g~v for 5 rain. The supernatant was centrifuged for 1 h at 100000 • ga~-The pellet was resuspended in water (tenfold volume), boiled for 5 rain and spun down for 10 min at 2500 • g~y. This procedure increases the yield of heat stable chromogranins/secretogranins (Rosa et al. 1985) and prevents proteolytic artifacts. The lyophilized supernarant was used for the electrophoresis. Analogous results were obtained when frozen pancreatic tissue was first freeze-dried, sliced with a razor into small pieces and homogenized with water followed by boling for 5 min. Soluble proteins of chromaffiu granules t00 4=Grube et al. 1986 were isolated as already described .
Immunoreplicas were obtained by the method of Burnette (1981) as described previously (Fischer-Colbrie and Frischenschlager 1985) . Instead of 5% bovine serum albumin 2% lipid free instant milk was used as a blocking reagent. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (Laemmli 1970) with an acrylamide gradient ranging from 10 to 17 % and two-dimensional electrophoresis (according to O'Farrel 1975) were performed as already described in detail (Fischer-Colbrie et al. 1984) .
Immunohistochemistry
Tissue preparation. Small tissue specimens of the bovine pancreas were quenched in melting Freon 22 preeooled with liquid nitrogen, freeze-dried, and fixed by vapor-phase p-formaldehyde. Subsequently, the specimens were immersed in propylene oxide and embedded in epoxy resin (araldite). Specimens from the bovine adrenal medulla, which served as reference organ, were treated in the same way. Serial semithin sections were cut at 0.5 ~tm and mounted on microscopic slides by heat (90 ~ C, 30 min). The resin was removed from the sections by Na-methoxide (Mayor et al. 1961) .
Antisera. The antisera against chromogranin A and B, and secretogranin II were raised in the Department of Pharmacology (Innsbruck). The antisera against the established pancreatic hormones (insulin, glucagon, somatostatin, pancreatic polypeptide = PP)were either purchased commercially or kindly provided by other groups. All of these antisera (except the insulin antiserum A564) have been characterized during previous immunohistochemical studies. All antisera are listed in Table 1 . The insulin antiserum A564 as compared to the insulin antiserum LAA (Novo, Denmark) -showed immunostaining of pancreatic insulin (B-) cells exclusively.
Immunohistochemical protocol
Throughout all investigations the peroxidase-anti-peroxidase (PAP) technique of Sternberger (1979) was used. This technique has been modified and standardized for the application on semithin sections (Grube 1980) . Serial semithin sections were sequentially immunostained for the chromogranins/secretogranin II or for the established pancreatic hormones. The working dilutions of the antisera (see Table 1 ) were determined by running ascending dilutions of the antisera from 1:1000 to 1:16000. For immunohistochemistry of the chromogranins the buffer used as diluent and as rinsing solution turned out to be of crucial importance. Thus, the use of phosphate-buffered saline (PBS) produced immunostaining of low intensities in both the adrenal medulla and the pancreas. Therefore, 50 mM Tris-HC1 (pH 7,6) was used as diluent for the chromogranin antisera and as rinsing solution.
Spec~ty controls
All controls to prevent non-specific immunostaining caused by the method or by antibody non-specifities were performed as recommended in the literature (Sternberger 1979; Grube 1980 ). The controls confirmed the specificities of all immunohistochemical findings (see also Grube et al. 1986) .
Results
Immunoblotting
These studies were performed with boiled extracts (see method section) of fetal bovine pancreas. Figure I presents the results. With an antiserum against chromogranin A a strong reaction was obtained. In electrophoresis the major immunoreactive band behaved identically to chromogranin A of adrenal origin. In the pancreatic extracts a band migrating slower than chromogranin A also stained significantly. Such staining could also be seen with chromaffin granules when higher protein amounts were applied (results not shown). It has already been established that this band corresponds to a special form of chromogranin A, containing highly sulfated proteoglycan chains (Falkensammer et al. 1985b; Rosa et al. 1985) . Figure 1 demonstrates that the pancreas contains a relatively high concentration of this special form of chromogranin A. In addition, both chromatin granules and pancreas contain several smaller immunoreactive bands which at least for chromaffin granules have been shown to represent breakdown products formed by endogenous proteolytic processing of chromogranin A (see Winkler et al. 1986) .
Chromogranin B and secretogranin II were also detected in immunoblots (Fig. 1) . However the reaction was significantly less intense and therefore more protein had to be applied and longer exposure times had to be chosen. For both antigens the pancreas contained immunoreactive bands which correspond to the largest component present in chromaffin granules. For secretogranin II, one strongly staining band of Mr 31000 was present, which had no counterpart in chromaffin granules. In two dimensional immunoblots (Fig. 2) this immunoreactive band had a pI similar to that of the larger component, which is typical for breakdown products formed by endogenous proteases (see Winkler et al. 1986 ). The position (pI and Mr) of the larger component (SG II in Fig. 2 ) is identical to that of the adrenal antigen (compare Fischer-Colbrie et al. 1986 ).
Immunohistochemistry
Adrenal medulla. In the bovine adrenal medulla the antiserum against chromogranin A revealed an intense immunostaining of endocrine cells. All of these cells were also heavily immunoreactive for chromogranin B (Fig. 3 a, b) . For Fig. 1 . Immunoblotting of soluble proteins of bovine chromaffin granules and of extracts of bovine fetal pancreas. The samples were subjected to one dimensional sodium dodecyl sulphate gel electrophoresis (acrylamide gradient from 10 to 17%) followed by immunoblotting. Antisera used were: Antichromogranin A (a-A), anti-chromogranin B (a-B), anti-secretogranin II (a-SG II). For each antiserum soluble proteins of chromaffin granules (a) and boiled extracts (218 ~tg protein for a -A and 715 gg for a -B and a -S G 1i) of fetal pancreas (b) were compared. In chromaffin granules the smaller immunoreactive proteins are due to breakdown products produced by the endogenous proteases of chromaffin granules (see Winkler et al. 1986) 8.6 The sample was subjected to two dimensional electrophoresis followed by immunoblotting. An antiserum against secretogranin II (a-SG II) was used secretogranin II most of the cells exhibited only a weak staining, however, only in a minority of cells a strong immunoreactivity was observed. The latter cells were also immunoreactive for chromogranin A and chromogranin B (Fig. 3) .
Endocrine pancreas. Confirming previous studies on this subject, the antiserum against chromogranin A immunostained all endocrine cell types of the pancreas except the PP-cells which only sporadically showed chromogranin Alike immunoreactivities (see Ehrhart et al. 1986 ). For chromogranin B, only very weak and diffuse staining of the islet cells was observed which did not allow to define an exact cellular localization. Concerning immunoreactivities for secretogranin II, immunostaining of the various endocrine cell types and the densities of staining were largely dependent on the dilution of the antiserum. When diluted 1 : 1000 (unde r these conditions a strong immunostaining was observed in the adrenal medulla), all insulin (B-)cells were only faintly positive for secretogranin II (Fig. 4) . At higher dilutions of the secretogranin II antiserum (1 : 2000), B-cells were very weakly immunoreactive or immunostaining was totally absent (Fig. 6) .
In addition to faintly secretogranin II-immunoreactive B-cells, other endocrine cells showed a dense immunostainlug for secretogranin [I. These cells turned out to be PP-cells when adjacent semithin sections were immunostained for pancreatic polypeptide (Figs. 5 and 7) . In PP-cells, the densities of immunostaining were less dependent on the concentration of the antiserum. Hence, these cells -like adrenal medullary ceils -showed secretogranin II-like immunoreactivities even when the antiserum used was diluted up to 1:4000. A certain proportion of secretogranin II-immunoreactive PP-cells exhibited very weak immunoreactivities for chromogranin A (Fig. 5 ), others were completely negative for chromogranin A (not shown). However, we also observed PP-cells which exhibited dense immunostainings for both chromogranin A and secretogranin II (Fig. 6) . Finally, a minority of PP-cells were completely negative for chromogranin A and secretogranin II (see Table 2 ).
The glucagon (A-) cells were comparable to the B-cells.
Both showed a moderate or faint immunostaining for secretogranin II only at higher concentrations of the secretogranin II antiserum (Fig. 7) . Somatostatin (D-) cells, which show a moderate or faint immunostaining for chromogranin A (see also Ehrhart et al. 1986 ), were unreactive towards the secretogranin II antiserum (Fig. 8 , Table 2 ).
Discussion
Boiled extracts of fetal bovine pancreas were used for immunoblotting. Boiling enriches the heat-stable chromogranins/secretogranins (Rosa et al. 1985) and in addition is efficient in preventing proteolytic degradation. Fetal pancreas was used since before birth the endocrine tissue represents a relatively high proportion of this organ. With such pancreatic extracts characteristic bands were obtained with antisera against chromogranin A and B and secretogranin II. A comparison with the proteins of chromaffin granules revealed that for each adrenal large molecular weight form a corresponding band exists in the pancreatic extract. This indicates that adrenal medullary and pancreatic endocrine cells synthesize chromogranin/secretogranin molecules of identical sizes. For chromogranin A this confirms results obtained with the human pancreas ), but disagrees with studies on rat insulinoma granules where the major immunoreactive band was found to be much smaller than the adrenal chromogranin A (Hutton et al. 1985) . This may be due to a species difference, but may also be caused by proteolysis during preparation of the sample which is a serious problem in such studies. Concerning the additional immunoreactive bands differences have been observed between adrenal medulla and the pancreas. In the latter organ a relatively large amount of a higher molecular weight form of chromogranin A is present probably representing a proteoglycan (Rosa et al. 1985; Falkensammer et al. 1985) . In addition, the endocrine pancreas contained a significant amount of a smaller component of secretogranin II which was apparently absent from adrenal medulla. This is in accordance with previous observations that the proteolytic processing of the chromogranins varies considerably amongst endocrine organs.
The immunohistochemical findings established that specific staining was confined to the endocrine pancreas. In addition, our studies revealed that the various types of the chromogranins/secretogranin can be localized in different endocrine cell types: in agreement with previous results (Ehrhart et al. 1986; Grube et al. 1986 ) chromogranin A is mainly contained in A-and B-cells, to a lesser extent in D-cells, and only in a minority of PP-cells. On the other hand, secretogranin II occurs mainly in PP-cells and to a lesser extent in A-and B-cells, but not in D-cells. For chromogranin B the immunohistochemical staining was too weak to allow an exact cellular localization.
How can these immunohistochemical data be correlated with the immunoblotting results? As shown by the latter method chromogranin A was apparently present in the highest concentration. In agreement, a strong immunohistochemical staining was found in a majority of cells. Secretogranin II gave a much weaker reaction in immunoblotting. However as shown by immunohistochemistry it was concentrated in a small subpopulation of cells (PP-cells) which were strongly stained. Chromogranin B gave the weakest reaction in immunoblotting. Apparently within the islets this antigen is not concentrated in any of the cell populations, thus the small amounts present could not be visualized in a reliable way by immunohistochemistry.
Our studies demonstrate that the PP-cells, with respect to the distribution of these antigens are a heterogenous cell population. At least four different types of PP-cells could be discerned following this parameter: 1. PP-cells with a strong immunostaining for both, chromogranin A and secretogranin II; 2. PP-cells with a strong immunostaining for secretogranin II and a faint immunostaining for chromogranin A; 3. PP-cells with a strong immunostaining for secretogranin II and no immunostaining for chromogranin A; 4. PP-cells containing no immunoreactivities for chromogranin A and secretogranin II. At present, no information is available about the reasons for the heterogeneity of pancreatic PP-cells. Future investigations will show whether the heterogeneity of PP-cells depends on the different types of islets described in the bovine pancreas (see Ei-Nady et al. 1982; Bonner-Weir and Like 1980) .
Insulin and gtncagon cells -as compared to PP-cells exhibit a tess dense immunostaining for secretogranin II, which require in addition relatively high concentrations of the secretogranin II antiserum. These weak immunoreactivities may be due to the low amounts of secretogranin II in insulin and glucagon cells, or due to the inaccessibility of the epitopes of secretogranin II in the secretory vesicles of B-and A-cells. The hormones themselves could prevent interaction of the antibody with secretogranin II since the immunoreactivities for chromogranins in pancreatic endocrine cells often are inversely related to the densities of the corresponding peptide immunoreactivities .
The fact that basically all pancreatic endocrine cell types contain chromogranins and secretogranin II should be seen (Helle et al. 1985) . Apparently chromogranin A is also involved in the binding of Ca 2 + within the chromaffin vesicles (Reiffen and Gratzl 1986a, b) . Within the secretion granules of pancreatic endocrine cells chromogranin immunoreactivities are mainly localized in the periphery of the granules whereas their center (core) is heavily immunoreactive for the pancreatic hormones (Varndell etal. 1985; Ehrhart et al. 1986; ). Interestingly, the intragranular localizations of the chromogranins and of Ca 2 + (see Ravazzola et al. 1976; Lenzen and K16ppel 1984) are the same. This suggests that also in pancreatic endocrine cells the chromogranins are involved in the binding of Ca 2+.
In addition recent studies indicate that the newly discovered putative hormone pancreastatin (Tatemoto et al. 1986 ) exhibits a striking structural similarity to chromogranin A (Eiden 1987; Huttner and Benedum 1987) . Pancreastatin inhibits the first rapid phase of glucose-stimulated insulin secretion (Tatemoto et al. 1986 ). Thus chromogranin A, secreted by pancreatic islet cells as a precursor of pancreastatin, may have an important function in the regulation of insulin secretion. 
